Pascal George, Phd, Mrsc Email & Phone Number

Paris, France

Paris Region

Consultancy of R&D projects for start-up’s, biotechs, strategy and operations coordination, advising-coaching-training scientists for optimizing their projects according to high industrial standards.Project evaluation and due diligence for investors, Venture Capitals. This covers all aspects of pharmaceutical research. Target Druggability assessment, Hit to lead and Lead Optimization, Biochemistry, Biology, Medicinal Chemistry, ADMET, early CMC, IP strategy and operations. Contacts and coordination of activities with CRO’s. Preparation of technical and scientific reports. Advising in decision making. Risk assessment. Developpability evaluation.Networking.

Paris, France

Région De Paris, France

In charge of the SCT Business Development team, for developing the SCT network, partnerships and collaborations with Public institutions, Universities, Foundations, Federations, national and international Scientific Societies, Pharma companies, SME's, biotech's having Pharmaceutical R&D activities with an emphasis in biology, drug discovery chemistry and life science.New activity : scientific coaching of R&D projects by senior experienced research managers (a team of 4), for academic and biotech labs. Audits, expertises and due diligences of early and mature research programs in life sciences.

Paris Region

Non-profit scientific organization focused on life science and drug discovery, association Loi 1901, contact at president@sct-asso.frThe SCT promotes multidisciplinary knowledges in the major pharma R&D domains, particularly in drug design and selection, chemical biology, medicinal chemistry, ADME-T.The society organizes once a year an international meeting in medicinal chemistry covering the above-mentioned topics, in addition to focused meetings for young researchers, spring and automn workshops on dedicated topics SCT allocates awards and grants, encouraging young scientists to embrass this carreer.

Strong Scientific Expertise in R&D Pharma Research (with strong relationships with US, EU, JP) and related domains (chemistry, biology, drug metabolism and safety, development, external collaborations with academic and industrial partners, intellectual property, management of multidisciplinar projects, juries and commissions, scientific evaluations, presentations, seminars and conferences - in english, and french). Adviser and scientific expert for R&D Health and related activities.This is covering particularly translational research activities (Biological targets, HTS, Lead evaluation, Research and Optimization programs, Drug Candidate delivery, in Vitro Models, DMPK and physicochemical parameters, Safety, Patent, preclinical studies...), also Research Strategy, Scientific expertise's. The privileged domains of activity are pharmaceutic, biology, chemistry, DMPK, Toxicology, but could cover also cosmetic, nutritional, agronomic, plants, environmental areas.

Strasbourg, France

Reviews of the scientific research projects of the Medalis laboratories and research groups.The SAB was constituted of 8 members from parma industry (5), academic research laboratories (2) and one patent expert. Reviews twice a year.

please contact president@SCT-asso.fr to reach SCT President and vice-president

Expertises of projects, international partnerships and collaboration managed by the high education and research ministry

Scientific evaluation of projects submitted to ANR, in the field of organic chemistry or medicinal chemistry

Scientific evaluation of projects submitted to ANR, in the field of organic chemistry or medicinal chemistry, particularly for young researchers

Former Senior Scientific Officer and Coordinator (Feb -Sept 2010), in Therapeutic Strategic Unit Aging (TSU Aging) in charge of interfaces of TSU with other dpts, in particular Lead Generation and Candidate Realization, Patent Dpt, and potentiallly with Exploratory Unit, Early to candidate DPU, DMPK-Safety.In charge of internal interfaces between clusters in particular for Medicinal Chemistry, Structure-Tox Relations, IP, External Collaborations, Strategic Advices

Head of CNS Medicinal Chemistry SARD, Worldwide (FR and USA)Local head of CNS research in Bagneux (Paris)

Head of CNS Medicinal Chemistry SSR,head of CNS research Bagneux (Paris)

Bagneux - France

Researcher, post-doc, CNS, Exploratory chem. groups (1978-1980)Team leader, Inflammation group, (1980-1981)Project leader , Task Force group in Chemistry, (1981-1982),CNS Medicinal chemistry deputy group head (1982-1986)CNS Medicinal chemistry group head (1986-1990)Section leader (2 groups) CNS Medicinal chemistry (90-92)Research Director CNS Medicinal chemistry (5 groups) (92-99)Discovery board member (92-99)Top mamangers Board member (Synthelabo) 99-00

Head of CNS Medicinal Chemistry Section, 3 groups of about 10 chemists each, a team of molecular modelling and a small team of parallel synthesis. Dedicated to programs targeting psychiatric and neurologic diseases. Management of transversal programs (target to drug candidate). General coordinator for Scientific databases systems (chemistry-biology-ADME-tox). Member of predictive Medchem-Tox models team. OPEX-CAPEX. Member of the CNS board, Member of Discovery Research Board. Member of Senior Directors board (99-).

Head of CNS Medicinal Chemistry with the leadership of 3 groups of 10 chemists each, in addition to molecular modelling and a small team of parallel synthesis. Dedicated to programs targeting psychiatric and neurologic diseases. Management of transversal programs (target to drug candidate). Project leader. OPEX-CAPEX. Member of the CNS board, Member of Discovery Research Board. Member of Senior Directors board.

Doctor Of Philosophy (Ph.D.), Docteur Ès Science, Chemistry

Activities and Societies: PhD thesis with Professor Heinz-Gunther VIEHE, on syntheses of heterocyles

Bs, Ms (Licence), Chemistry